Chanelle Pharma Appoints Pat McLoughlin as General Manager
10th January’2025, GALWAY – Chanelle Pharma, Ireland’s largest manufacturer of generic pharmaceuticals for human and animal health, is delighted to announce the appointment of Pat McLoughlin as General Manager.
In his new role, Pat will oversee all operations across Manufacturing,
Engineering, OPEX, Supply Chain, Quality Control (QC), and Facilities. With
more than 20 years of senior management experience in the pharmaceutical,
medical device, and consumer healthcare industries, Pat brings unparalleled
expertise in enhancing operational efficiency and optimising business
functions.
CEO
Angelo Gatto remarked,
“Pat’s outstanding leadership and proven track record in operational excellence
will be key to accelerating Chanelle Pharma’s growth and transformation. We are
thrilled to welcome him to the team and look forward to his leadership in
shaping the future of our operations.”
Pat
McLoughlin added, “I
am excited to join Chanelle Pharma at such a pivotal time in its journey. The
company’s commitment to innovation and its dedication to delivering
high-quality products globally is truly inspiring. I look forward to working
with the talented team to build on this legacy and drive continued success.”
About
Pat McLoughlin
Pat
McLoughlin has over two decades of experience in senior leadership roles at
renowned organisations such as B. Braun & GlaxoSmithKline. His
extensive experience includes leading global manufacturing sites, spearheading
major business transformations, and advancing safety and compliance standards.
His strategic vision and ability to execute complex initiatives will be
instrumental as Chanelle Pharma continues its expansion. His expertise spans
business growth through strategic leadership, process optimization, and team
development, with a strong emphasis on operational excellence and quality
improvements.
About Chanelle Pharma
Chanelle
Pharma is Ireland’s largest manufacturer of generic pharmaceuticals for human
and animal health. Headquartered in Loughrea, Ireland, the company employs more
than 700 people across Ireland, the UK, Portugal, and Jordan. With four
manufacturing and five R&D facilities, Chanelle Pharma operates to the
highest regulatory standards and exports to over 80 countries worldwide. In
February 2024, Chanelle Pharma was acquired by Exponent, a leading European
private equity firm.
For more
information, please visit www.chanellepharma.com or
connect with us on LinkedIn.
